Literature DB >> 14502505

Anti-HIV activity of HEPT, TIBO, and cyclic urea derivatives: structure-property studies, focused combinatorial library generation, and hits selection using substructural molecular fragments method.

V P Solov'ev1, A Varnek.   

Abstract

Substructural molecular fragments (SMF) method [Solov'ev, V. P.; Varnek, A.; Wipff, G. J. Chem. Inf. Comput. Sci. 2000, 40, 847-858] was applied to assess anti-HIV activity for large data sets for three families of compounds: 1-[2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives, tetrahydroimidazobenzodiazepinone (TIBO) derivatives, and cyclic urea (CU) derivatives. The SMF method uses 49 types of topological descriptors (atom/bond sequences and "augmented atoms") which, being coupled with 3 linear and nonlinear fitting equations, allows the user to generate up to 147 structure-property models. For each family of compounds, the modeling was performed on several training sets followed by the validation calculations where three best fit models were applied. Calculated activities well reproduce available experimental data. On the basis of the "optimal" molecular fragments, the focused combinatorial library containing 252 virtual HEPT derivatives has been generated. Its filtering led to several hits potentially possessing anti-HIV activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14502505     DOI: 10.1021/ci020388c

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  2 in total

1.  Substructural fragments: an universal language to encode reactions, molecular and supramolecular structures.

Authors:  A Varnek; D Fourches; F Hoonakker; V P Solov'ev
Journal:  J Comput Aided Mol Des       Date:  2005-11-16       Impact factor: 3.686

2.  Multi-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study.

Authors:  Qi Liu; Han Zhou; Lin Liu; Xi Chen; Ruixin Zhu; Zhiwei Cao
Journal:  BMC Bioinformatics       Date:  2011-07-20       Impact factor: 3.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.